These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 19700099)

  • 21. One-Year Outcomes of the Paclitaxel-Eluting, Self-Expanding Stentys Stent System in the Treatment of Infrapopliteal Lesions in Patients With Critical Limb Ischemia.
    Bosiers M; Callaert J; Keirse K; Hendriks JMH; Peeters P; Verbist J; Maene L; Beelen R; Deloose K
    J Endovasc Ther; 2017 Jun; 24(3):311-316. PubMed ID: 28351310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Below-knee bare nitinol stent placement in high-risk patients with critical limb ischaemia and unlimited supragenicular inflow as treatment of choice.
    Donas KP; Schwindt A; Schönefeld T; Tessarek J; Torsello G
    Eur J Vasc Endovasc Surg; 2009 Jun; 37(6):688-93. PubMed ID: 19328021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-Effectiveness of Drug-Eluting Stents for Infrapopliteal Lesions in Patients with Critical Limb Ischemia: The PADI Trial.
    Wakkie T; Konijn LCD; van Herpen NPC; Maessen MFH; Spreen MI; Wever JJ; Statius van Eps RG; Veger HT; van Dijk LC; Mali WPTM; van Overhagen H
    Cardiovasc Intervent Radiol; 2020 Mar; 43(3):376-381. PubMed ID: 31807849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two-year analysis of the Japanese cohort from the Zilver PTX randomized controlled trial supports the validity of multinational clinical trials.
    Ohki T; Yokoi H; Kichikawa K; Kimura T; Snyder SA; Ragheb AO; O'Leary EE; Jaff MR; Ansel GM; Dake MD
    J Endovasc Ther; 2014 Oct; 21(5):644-53. PubMed ID: 25290792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-eluting stent implantation.
    Iaccarino D; Politi L; Rossi R; Sgura F; Monopoli D; Modena MG; Sangiorgi GM
    J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):536-43. PubMed ID: 20090547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence, anatomical location, and clinical significance of compressions and fractures in infrapopliteal balloon-expandable metal stents.
    Karnabatidis D; Katsanos K; Spiliopoulos S; Diamantopoulos A; Kagadis GC; Siablis D
    J Endovasc Ther; 2009 Feb; 16(1):15-22. PubMed ID: 19281287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative Effectiveness of Plain Balloon Angioplasty, Bare Metal Stents, Drug-Coated Balloons, and Drug-Eluting Stents for the Treatment of Infrapopliteal Artery Disease: Systematic Review and Bayesian Network Meta-analysis of Randomized Controlled Trials.
    Katsanos K; Kitrou P; Spiliopoulos S; Diamantopoulos A; Karnabatidis D
    J Endovasc Ther; 2016 Dec; 23(6):851-863. PubMed ID: 27708143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bifurcation stenting after failed angioplasty of infrapopliteal arteries in critical limb ischemia: techniques and short-term follow-up.
    Werner M; Scheinert S; Bausback Y; Bräunlich S; Ulrich M; Piorkowski M; Scheinert D; Schmidt A
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E522-8. PubMed ID: 23404942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial.
    Dake MD; Ansel GM; Jaff MR; Ohki T; Saxon RR; Smouse HB; Machan LS; Snyder SA; O'Leary EE; Ragheb AO; Zeller T;
    Circulation; 2016 Apr; 133(15):1472-83; discussion 1483. PubMed ID: 26969758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug eluting balloons.
    Diehm NA; Hoppe H; Do DD
    Tech Vasc Interv Radiol; 2010 Mar; 13(1):59-63. PubMed ID: 20123434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Major adverse limb events and wound healing following infrapopliteal artery stent implantation in patients with critical limb ischemia: the XCELL trial.
    Rocha-Singh KJ; Jaff M; Joye J; Laird J; Ansel G; Schneider P;
    Catheter Cardiovasc Interv; 2012 Nov; 80(6):1042-51. PubMed ID: 22605682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wound Healing Outcomes and Health-Related Quality-of-Life Changes in the ACHILLES Trial: 1-Year Results From a Prospective Randomized Controlled Trial of Infrapopliteal Balloon Angioplasty Versus Sirolimus-Eluting Stenting in Patients With Ischemic Peripheral Arterial Disease.
    Katsanos K; Spiliopoulos S; Diamantopoulos A; Siablis D; Karnabatidis D; Scheinert D
    JACC Cardiovasc Interv; 2016 Feb; 9(3):259-267. PubMed ID: 26777329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome analysis of infrapopliteal percutaneous transluminal angioplasty and bypass graft surgery with nonreversed saphenous vein for individuals with critical limb ischemia.
    Casella IB; Brochado-Neto FC; Sandri Gde A; Kalaf MJ; Godoy MR; Costa VS; Matielo MF; Sacilotto R
    Vasc Endovascular Surg; 2010 Nov; 44(8):625-32. PubMed ID: 20724288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous Transluminal Angioplasty and Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia (PADI) Trial.
    Spreen MI; Martens JM; Hansen BE; Knippenberg B; Verhey E; van Dijk LC; de Vries JP; Vos JA; de Borst GJ; Vonken EJ; Wever JJ; Statius van Eps RG; Mali WP; van Overhagen H
    Circ Cardiovasc Interv; 2016 Feb; 9(2):e002376. PubMed ID: 26861113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Value of drug-eluting stents after failed percutaneous transluminal angioplasty in the infrapopliteal vessels for the treatment of critical limb ischemia: favorable mid-term patency and limb salvage results.
    Lookstein R; Ward T; Kim E; Fischman A; Nowakowksi F; Ellozy S; Teodorescu V; Vouyouka A; Faries P; Weintraub J
    J Cardiovasc Surg (Torino); 2011 Aug; 52(4):461-6. PubMed ID: 21792153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bare metal stent versus paclitaxel eluting stent for intermediate length femoropopliteal arterial lesions (BATTLE trial): study protocol for a randomized controlled trial.
    Gouëffic Y; Kaladji A; Guyomarch B; Montagne C; Fairier D; Gestin S; Riche VP; Vent PA; Chaillou P; Costargent A; Patra P
    Trials; 2014 Oct; 15():423. PubMed ID: 25359394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolving modalities for femoropopliteal interventions.
    Ansel GM; Lumsden AB
    J Endovasc Ther; 2009 Apr; 16(2 Suppl 2):II82-97. PubMed ID: 19624076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug eluting stents for below the knee lesions in patients with critical limb ischemia : long-term follow-up.
    Rosales OR; Mathewkutty S; Gnaim C
    Catheter Cardiovasc Interv; 2008 Jul; 72(1):112-5. PubMed ID: 18412272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infrapopliteal stenting with silicon carbide-coated stents in critical limb ischemia: a 12 month follow-up study.
    Atar E; Avrahami R; Koganovich Y; Litvin S; Knizhnik M; Belenky A
    Isr Med Assoc J; 2009 Oct; 11(10):611-4. PubMed ID: 20077948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial.
    Fanelli F; Cannavale A; Boatta E; Corona M; Lucatelli P; Wlderk A; Cirelli C; Salvatori FM
    J Endovasc Ther; 2012 Oct; 19(5):571-80. PubMed ID: 23046320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.